Neurology® Podcast

Dr. Tesha Monteith talks with Dr. Patricia Pozo-Rosich about the latest advancements in headache medicine, focusing on key research findings from 2025. Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about the latest findings from the 2026 International Stroke Conference. Read more about the CHOICE-2 trial. Read more about the OCEANIC-STROKE trial. Read more about the FASTEST trial. Disclosures can be found at Neurology.org.

The March 2026 recall showcases four previously posted episodes focused on clinical issues relevant to hospital-based neurologists. The episode opens with Dr. Jennifer E. Fugate discussing PRES, focusing on clinical presentation, diagnostic criteria, neuroimaging findings, and management strategies. The episode continues with Dr. Ava Easton discussing the World Health Organization's technical brief on encephalitis. In the third episode, Dr. Matthew Ryan Woodward discusses the complexities of status epilepticus, from definition through refractory and super-refractory stages. The episode concludes with Dr. Adrian Budhram discussing common challenges neurologists face when interpreting CSF results. Podcast links: Evolving Insights into the Diagnosis, Management, and Outcomes of PRES WHO Launches Technical Brief for Encephalitis Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication CSF Correction Factors for Traumatic Lumbar Puncture in Adults Article links: Posterior Reversible Encephalopathy Syndrome: Evolving Insights in Diagnosis, Management, and Outcomes WHO Launches Technical Brief for Encephalitis Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication Clinical Utility of CSF Correction Factors for Traumatic Lumbar Puncture in Adults Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Shyam Prabhakaran about the 2026 AHA/ASA guidelines for the early management of acute ischemic stroke, highlighting key recommendations, the role of advanced imaging, and the importance of thrombolysis and thrombectomy. Read the related article in the journal Stroke. Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Marjo S. van der Knaap and Romy J. van Voorst about expert consensus recommendations for the diagnosis and management of vanishing white matter and the importance of standardizing care worldwide. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Alex Menze talks with Dr. Divyanshu Dubey about the clinical insights into autoimmune nodopathies, particularly focusing on CASPR1 and CASPR1/CNTN1-complex-IgG. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Halley Alexadner talks with Dr. Alissa M. D'Gama about genetic testing for infantile epilepsies. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Greg Cooper talks with Dr. David G. Coughlin about the role of αSyn-SAAs in diagnosing dementia with Lewy bodies and their relationship with Alzheimer disease biomarkers. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Tesha Monteith talks with Dr. Andrew D. Hershey about the advancements in the treatment of pediatric migraines. Read the related article in The New England Journal of Medicine. Disclosures can be found at Neurology.org.

In this special episode, Dr. Roy Strowd talks with Drs. Jeff Ratliff, Tesha Monteith, and Justin Abbatemarco about non-traditional educational formats and how they're reshaping neurology training. Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Dipika Aggarwal as she shares her profound journey as both a physician and a patient. After battling stage four colon cancer, she faced a stroke that changed her life. Disclosures can be found at Neurology.org.

The February 2026 recall features four previously posted episodes on multiple sclerosis. The episode begins with a conversation with Dr. Wallace J. Brownle discussing whether dissemination in time is essential to diagnois relapsing MS. The discussion continues with Dr. Daniel Ontaneda regarding the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis. The episode then transitions into a conversation with Dr. Jiwon Oh about BTK inhibitors and recent data on tolebrutinib in multiple sclerosis. The episode concludes with Dr. Sandra Vukusic addressing the differences in disease-modifying therapies for female versus male patients with multiple sclerosis. Podcast link: Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS 2024 McDonald Criteria BTK Inhibitors in Multiple Sclerosis Treatment Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis Podcast article: Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing Multiple Sclerosis Diagnosis of Multiple Sclerosis: 2024 Revisions of the McDonald Criteria Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis Disclosures can be found at Neurology.org.

Dr. Tesha Monteith talks with Dr. Michael Eller about the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. John Ney about the prevalence, disability burden, and societal impact of neurologic disorders in the U.S. Read the related article in JAMA. Disclosures can be found at Neurology.org.

In the second episode of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the management of non-arteritic ischemic optic neuropathy and its emerging relationship with GLP‑1 medications. Disclosures can be found at Neurology.org.

In part one of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the clinical features and diagnostic tools utilized for non-arteritic ischemic optic neuropathy (NAION). Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Divyanshu Dubey about how antibodies to synaptophysin and GAP43 help explain an autoimmune neuropathy seen in swine abattoir workers and offer new clues for diagnosing and treating related inflammatory neuropathies. Read the related article in ScienceDirect. Disclosures can be found at Neurology.org.

In the second installment of this two-part series, Dr. Stacey Clardy talks with Drs. Ayush Gupta and Kuntal Sen about the spinal cord and optic neuritis, while outlining practical approaches to genetic testing and emphasizing the importance of collaboration with genetic counselors and neurogeneticists. Read the related article in Neurology Genetics. Disclosures can be found at Neurology.org.

In part one of this two-part series, Dr. Stacey Clardy talks with Drs. Ayush Gupta and Kuntal Sen about the phenotypes commonly seen in CNS inflammatory and demyelinating diseases, and discuss genetic conditions in patients who do not precisely meet classic diagnostic criteria. Read the related article in Neurology Genetics. Disclosures can be found at Neurology.org.

Dr. Elizabeth Coon talks with Prof. Franziska Hopfner about the frequency and disease trajectory of MSA patients who do not experience dysautonomia, in comparison to those with autonomic involvement. Read the related article in Neurology®. Disclosures can be found at Neurology.org.